Hiroteru Kamimura
Overview
Explore the profile of Hiroteru Kamimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
[Liver disease and sarcopenia:the future of rehabilitation medicine -it has to be fun to keep going]
Terai S, Kamimura H
Nihon Shokakibyo Gakkai Zasshi
. 2023 Sep;
120(9):701-708.
PMID: 37690825
No abstract available.
12.
Kimura N, Takahashi K, Setsu T, Goto S, Miida S, Takeda N, et al.
JGH Open
. 2023 Jun;
7(6):431-438.
PMID: 37359114
Background And Aim: Treatment response to ursodeoxycholic acid may predict the prognosis of patients with primary biliary cholangitis (PBC). Recent studies have suggested the benefits of using machine learning (ML)...
13.
Kamimura H, Setsu T, Kimura N, Miyazawa M, Kaneko S, Kamimura K, et al.
Hepatol Res
. 2023 Jan;
53(6):556-568.
PMID: 36680351
Aim: This study aimed to analyze the current trends of drug-induced liver-related adverse events in the Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event...
14.
Watanabe Y, Abe H, Kimura N, Arao Y, Ishikawa N, Yuichiro M, et al.
Hepatol Res
. 2023 Jan;
53(5):460-472.
PMID: 36628578
Aim: Acute-on-chronic liver failure (ACLF), a disease with poor prognosis, is reportedly caused by cellular senescence due to mitochondrial dysfunction. In this study, we described and analyzed the underlying mechanism...
15.
Sakai N, Kamimura K, Miyamoto H, Ko M, Nagoya T, Setsu T, et al.
J Gastroenterol
. 2022 Oct;
58(1):53-68.
PMID: 36301364
Background: To establish a treatment option for liver fibrosis, the possibility of the drug repurposing theory was investigated, with a focus on the off-target effects of active pharmaceutical ingredients. Methods:...
16.
Oda C, Kamimura K, Shibata O, Morita S, Tanaka Y, Setsu T, et al.
Biochem Biophys Rep
. 2022 Sep;
32:101352.
PMID: 36160029
Background: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) accounts for 10%-20% of the total HCC numbers. Its clinical features include the occurrence in the younger generation, large tumors, and poor...
17.
Ohkoshi-Yamada M, Kamimura K, Kimura A, Tanaka Y, Nagayama I, Yakubo S, et al.
Biochem Biophys Res Commun
. 2022 Aug;
625:116-121.
PMID: 35952608
Objective: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic dysregulation and is linked with various cardiovascular complications, which often lead to poor prognostic outcomes. To develop a standard therapy...
18.
Kimura N, Setsu T, Arao Y, Sakai N, Watanabe Y, Abe H, et al.
JGH Open
. 2022 Aug;
6(8):577-586.
PMID: 35928695
Background And Aim: Symptoms of primary biliary cholangitis (PBC) frequently impair one's quality of life (QOL). Nonetheless, with improved treatment, the prognosis of PBC also improves. QOL plays an important...
19.
Horigome R, Kamimura K, Niwa Y, Ogawa K, Mizuno K, Fujisawa K, et al.
J Clin Med
. 2022 Jul;
11(13).
PMID: 35806959
The dextran sodium sulfate (DSS)-induced colitis mouse model has been widely utilized for human colitis research. While its mechanism involves a response to double-strand deoxyribonucleic acid (DNA) damage, ataxia telangiectasia...
20.
Owaki T, Kamimura K, Ko M, Nagayama I, Nagoya T, Shibata O, et al.
Dis Model Mech
. 2022 Jun;
15(7).
PMID: 35765850
Serotonin (5-HT) is one of the key bioamines of nonalcoholic fatty liver disease (NAFLD). Its mechanism of action in autonomic neural signal pathways remains unexplained; hence, we evaluated the involvement...